Multichannel Ca2+ Generator for Synergistic Tumor Therapy via Intracellular Ca2+ Overload and Chemotherapy

Ca2+ overload has attracted an increasing attention due to its benefit of precise cancer therapy, but its efficacy is limited by the strong Ca2+ excretion of cancer cells. Moreover, monotherapy of Ca2+ overload usually fails to treat tumors satisfactorily. Herein, we develop a multifunctional nanosy...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Langmuir : the ACS journal of surfaces and colloids. - 1992. - 38(2022), 26 vom: 05. Juli, Seite 8012-8020
1. Verfasser: Hu, Taishun (VerfasserIn)
Weitere Verfasser: Liu, Xinli, Gong, Xiyu, Chen, Botao, Tan, Songwen, Xu, Hui, Pan, Anqiang, Liang, Shuquan, He, Yongju, Zhou, Fangfang
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2022
Zugriff auf das übergeordnete Werk:Langmuir : the ACS journal of surfaces and colloids
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Antineoplastic Agents Drug Carriers Silicon Dioxide 7631-86-9 Curcumin IT942ZTH98
LEADER 01000naa a22002652 4500
001 NLM342365029
003 DE-627
005 20231226013938.0
007 cr uuu---uuuuu
008 231226s2022 xx |||||o 00| ||eng c
024 7 |a 10.1021/acs.langmuir.2c00794  |2 doi 
028 5 2 |a pubmed24n1141.xml 
035 |a (DE-627)NLM342365029 
035 |a (NLM)35715215 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Hu, Taishun  |e verfasserin  |4 aut 
245 1 0 |a Multichannel Ca2+ Generator for Synergistic Tumor Therapy via Intracellular Ca2+ Overload and Chemotherapy 
264 1 |c 2022 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 07.07.2022 
500 |a Date Revised 24.08.2022 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Ca2+ overload has attracted an increasing attention due to its benefit of precise cancer therapy, but its efficacy is limited by the strong Ca2+ excretion of cancer cells. Moreover, monotherapy of Ca2+ overload usually fails to treat tumors satisfactorily. Herein, we develop a multifunctional nanosystem that could induce Ca2+ overload by multipathway and simultaneously produce chemotherapy for synergistic tumor therapy. The nanosystem (CaMSNCUR) is prepared by synthesizing a Ca-doped mesoporous silica nanoparticle (CaMSN) followed by loading the anticancer drug curcumin (CUR). CaMSN serves as the basis Ca2+ generator to induce Ca2+ overload directly in the intracellular environment by acid-triggered Ca2+ release, while CUR could not only exhibit chemotherapy but also facilitate Ca2+ release from the endoplasmic reticulum to the cytoplasm and inhibit Ca2+ efflux out of cells to further enhance Ca2+ overload. The in vitro and in vivo results show that CaMSN@CUR could exhibit a remarkable cytotoxicity against 4T1 cells and significantly inhibit tumor growth in 4T1 tumor-bearing mice via the synergy of Ca2+ overload and CUR-mediated chemotherapy. It is expected that the designed CaMSN@CUR has a great potential for effective tumor therapy 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Antineoplastic Agents  |2 NLM 
650 7 |a Drug Carriers  |2 NLM 
650 7 |a Silicon Dioxide  |2 NLM 
650 7 |a 7631-86-9  |2 NLM 
650 7 |a Curcumin  |2 NLM 
650 7 |a IT942ZTH98  |2 NLM 
700 1 |a Liu, Xinli  |e verfasserin  |4 aut 
700 1 |a Gong, Xiyu  |e verfasserin  |4 aut 
700 1 |a Chen, Botao  |e verfasserin  |4 aut 
700 1 |a Tan, Songwen  |e verfasserin  |4 aut 
700 1 |a Xu, Hui  |e verfasserin  |4 aut 
700 1 |a Pan, Anqiang  |e verfasserin  |4 aut 
700 1 |a Liang, Shuquan  |e verfasserin  |4 aut 
700 1 |a He, Yongju  |e verfasserin  |4 aut 
700 1 |a Zhou, Fangfang  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Langmuir : the ACS journal of surfaces and colloids  |d 1992  |g 38(2022), 26 vom: 05. Juli, Seite 8012-8020  |w (DE-627)NLM098181009  |x 1520-5827  |7 nnns 
773 1 8 |g volume:38  |g year:2022  |g number:26  |g day:05  |g month:07  |g pages:8012-8020 
856 4 0 |u http://dx.doi.org/10.1021/acs.langmuir.2c00794  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_22 
912 |a GBV_ILN_350 
912 |a GBV_ILN_721 
951 |a AR 
952 |d 38  |j 2022  |e 26  |b 05  |c 07  |h 8012-8020